The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) announced today that it has selected Shopify Inc. (“Shopify”) (NYSE:SHOP) (TSX:SHOP) to build an innovative ecommerce platform for the delivery of medical and future adult-use organic cannabis world-wide.
The Green Organic Dutchman Holdings Ltd. (TGOD) is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis in Canada. TGOD is developing large-scale production, global distribution channels and a premium brand to become the leading supplier of organic cannabis worldwide. TGOD is committed to building a powerful, scalable ecommerce solution, and is proud to implement Shopify’s innovative ecommerce platform.
Shopify is the leading cloud-based multichannel ecommerce platform. The company was involved in the partnership between TGOD and Epican Medicinals in Jamaica where they supplied the retail point-of-sale system for Epican’s retail outlets. Additionally, Shopify is developing the pre-registration system for medical patients throughout Jamaica. TGOD will leverage this expertise as it plans for the sale of organic cannabis in domestic and international markets.
“We are pleased to announce this agreement with ecommerce giant Shopify,” said Csaba Reider, President of TGOD. “We see tremendous value in this relationship and Shopify will play an instrumental role in our ability to rapidly scale and provide our premium organic cannabis to global markets.”
“We look forward to working with The Green Organic Dutchman on the development of their online store for medical and adult-use cannabis,” said Loren Padelford, VP & GM at Shopify. “Our platform will allow TGOD to rapidly scale and capitalize on emerging cannabis opportunities in a safe, secure, and reliable way.”
Investors looking to learn more about TGOD may visit the Company’s Investor Centre at https://tgod.ca/investor-centre/ or contact the Company at [email protected], and patients may now register for the Company’s beta patient program athttps://tgod.ca/patients/
E: [email protected]
T: 1 (416) 900-7621